- Nachrichtendetail
-
28.06.2024 16:33:21 - dpa-AFX: *J&J : RYBREVANT COMBINATION APPROVED IN EUROPE FOR FIRST-LINE TREATMENT OF NSCLC
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Xetra | 148,080 | 05.08.24 11:42:01 | -0,060 | -0,04% | 148,040 | 148,440 | 147,480 | 148,140 |
